[1] |
Yu B, Ma YJ, Tu YH, et al. Newly onset indirect traumatic optic neuropathy-surgical treatment first versus steroid treatment first[J]. Int J Ophthalmol, 2020,13(1):124-128. DOI:10.18240/ijo.2020.01.18.
|
[2] |
Rashad MA, Abdel LAAM, Mostafa HA, et al. Visual-evoked-response-supported outcome of intravitreal erythropoietin in management of indirect traumatic optic neuropathy[J]. J Ophthalmol, 2018, 2018:2750632. DOI: 10.1155/2018/2750632.
|
[3] |
Razeghinejad MR, Rahat F, Bagheri M. Levodopa-carbidopa may improve vision loss in indirect traumatic optic neuropathy[J].?J Neurotrauma, 2010, 27(10):1905-1909. DOI:10.1089/neu.2010.1362.
|
[4] |
Welsbie DS, Ziogas NK, Xu L, et al. Targeted disruption of dual leucine zipper kinase and leucine zipper kinase promotes neuronal survival in a model of diffuse traumatic brain injury[J]. Mol Neurodegener, 2019,14(1):44. DOI: 10.1186/s13024-019-0345-1.
|
[5] |
Watkins TA, Wang B, Huntwork-Rodriguez S, et al. DLK initiates a transcriptional program that couples apoptotic and regenerative responses to axonal injury[J]. Proc Natl Acad Sci USA, 2013,110(10):4039-4044. DOI: 10.1073/pnas.1211074110.
|
[6] |
Welsbie DS, Yang Z, Ge Y, et al. Functional genomic screening identifies dual leucine zipper kinase as a key mediator of retinal ganglion cell death[J]. Proc Natl Acad Sci USA, 2013,110(10):4045-4050. DOI: 10.1073/pnas.1211284110.
|
[7] |
Dapper JD, Crish SD, Pang IH, et al. Proximal inhibition of p38 MAPK stress signaling prevents distal axonopathy[J]. Neurobiol Dis, 2013,59:26-37. DOI: 10.1016/j.nbd.2013.07.001.
|
[8] |
Tedeschi A, Bradke F. The DLK signalling pathway--a double-edged sword in neural development and regeneration[J]. EMBO Rep, 2013,14(7):605-614. DOI:10.1038/embor.2013.64.
|
[9] |
Syc-Mazurek SB, Rausch RL, Fernandes KA, et al. Mkk4 and Mkk7 are important for retinal development and axonal injury-induced retinal ganglion cell death[J]. Cell Death Dis, 2018,9(11):1095. DOI:10.1038/s41419-018-1079-7.
|
[10] |
陈晓凤, 张敏, 武薇, 等. Activin A通过JNK/ERK信号通路调控皮肤成纤维细胞肌动蛋白重组的研究[J]. 中国临床解剖学杂志, 2018, 36(2):192-196. DOI:10.13418/j.issn.1001-165x.2018.02.014.
|
[11] |
Liu W, Li X, Chen X, et al. JIP1 deficiency protects retinal ganglion cells from apoptosis in a rotenone-induced injury model[J]. Front Cell Dev Biol, 2019, 7:225. DOI:10.3389/fcell.2019.00225.
|
[12] |
Fernandes KA, Harder JM, Fornarola LB, et al. JNK2 and JNK3 are major regulators of axonal injury-induced retinal ganglion cell death[J]. Neurobiol Dis, 2012, 46(2):393-401. DOI: 10.1016/j.nbd.2012.02.003.
|
[13] |
Kim BJ, Silverman SM, Liu Y, et al. In vitro and in vivo neuroprotective effects of cJun N-terminal kinase inhibitors on retinal ganglion cells[J]. Mol Neurodegener, 2016,11:30. DOI: 10.1186/s13024-016-0093-4.
|
[14] |
Fernandes KA, Harder JM, John SW, et al. DLK-dependent signaling is important for somal but not axonal degeneration of retinal ganglion cells following axonal injury[J]. Neurobiol Dis, 2014,69:108-116. DOI: 10.1016/j.nbd.2014.05.015.
|